FOXL2 and neoplasm: Based on this expanded analysis of IMC marker co-expression, FOXL2+COL1A1+ cells can be separated into two subgroups, one resembling FOXL2+COL1A1− tumor cells and the other with an immunophenotype resembling non-AGCT stromal cells.